Biotech →
- 15 Sep 2010
- Working Paper Summaries
From Bench to Board: Gender Differences in University Scientists’ Participation in Commercial Science
biotechnology field, was conducted by Haas School of Business professor Waverly W. Ding, MIT Sloan professor Fiona Murray, and HBS professor Toby E. Stuart. Key concepts include: University-employed scientists helped to found at least half of the publicly traded biotech firms in existence today. Closed for comment; 0 Comments.
- 15 Dec 2009
- First Look
First Look: Dec. 15, 2009
A first look at faculty research: Why multinationals group together overseas and what it means for foreign direct investment ... Leveraging know-how ... Case study: "Tengion: Bringing Regenerative Medicine to Life." Closed for comment; 0 Comments.
- 19 May 2009
- First Look
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
Despite the hundreds of billions of dollars invested in biotech in recent decades, most biotech companies do not turn a profit. Science-based companies require a different kind of leadership, which HBS intends to develop through research, analysis and teaching. Harvard's new science complex being built across from Harvard Business School presents many opportunities for cross-fertilization. Closed for comment; 0 Comments.
- 15 May 2007
- First Look
- 13 Nov 2006
- Research & Ideas
Science Business: What Happened to Biotech?
After thirty years the numbers are in on the biotech business—and it's not what we expected. The industry in aggregate has lost money. R&D performance has not radically improved. The problem? In a new book, Professor Gary Pisano points to systemic flaws as well as unhealthy tensions Closed for comment; 0 Comments.
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
Governmental, cultural and academic differences are hurting Europe’s chances of gaining on the U.S. Can anything be done? Closed for comment; 0 Comments.
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
What will it take for biotechnology to fulfill its economic potential? Participants need to think twice about the strategies and assumptions that are driving the industry, says HBS professor Gary P. Pisano. Closed for comment; 0 Comments.
- 23 Jul 2001
- Research & Ideas
How Relationships are Building Biotech
What's one way to give an industry a kick-start? According to HBS professor Monica C. Higgins, the power of professional relationships should never be underestimated. In this article, she outlines some of the key lessons now emerging from the earliest stages of a long research project on how careers create an industry—in this case, biotechnology. Higgins' work is also outlined in a chapter she wrote for the forthcoming volume from Oxford University Press, Career Creativity. Closed for comment; 0 Comments.
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
On the cusp of what most analysts agree will be the age of biotechology, Professor Gary P. Pisano and four HBS alums on the front lines of the biotech revolution offer their views of the challenges, issues and opportunities facing the industry in the laboratory, the boardroom and the marketplace. Closed for comment; 0 Comments.
First Look: October 15
Is science sexy? ... Michael Bloomberg's strategy for New York ... Does economic distress hamper innovation? Closed for comment; 0 Comments.